Active Chemical Molecule
Bortezomib (2.5mg)
Bortezomib (2.5mg) is a premium clinical composition utilized extensively under specialized clinical prescriptions.
Formulations based on "Bortezomib (2.5mg)" (3)
Anti Cancer DrugsVerified Supply
Bortecad 2.5mg Injection
Bortezomib (2.5mg)
Multiple myeloma and mantle-cell lymphoma are both treated by Bortecad 2.5mg Injection. It demonstrates its efficacy by halting or reducing the proliferation of cancer cells.
Specialty BrandCadila Pharmaceuticals Ltd
Unit DosageInjection (2.5mg)
Clinical SourceCadila Pharmaceuticals Ltd
Temp Tracked: Store below 25°C
Anti Cancer DrugsVerified Supply
Proteoz 2.5mg Injection
Bortezomib (2.5mg)
Multiple myeloma and mantle-cell lymphoma are both treated by Proteoz 2.5mg Injection. It demonstrates its efficacy by halting or reducing the proliferation of cancer cells.
Specialty BrandZydus Cadila
Unit DosageInjection (2.5mg)
Clinical SourceZydus Cadila
Temp Tracked: Store below 25°C
Anti Cancer DrugsVerified Supply
Borviz 2.5mg Injection
Bortezomib (2.5mg)
Multiple myeloma and mantle-cell lymphoma are both treated by Borviz 2.5mg Injection. It demonstrates its efficacy by halting or reducing the proliferation of cancer cells.
Specialty BrandIntas Pharmaceuticals Ltd
Unit DosageInjcetion (2.5mg)
Clinical SourceIntas Pharmaceuticals Ltd
Temp Tracked: Store below 25°C